• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌:临床病理学方面

Hepatocellular carcinoma: clinicopathological aspects.

作者信息

Okuda K

机构信息

Department of Medicine, Chiba University School of Medicine, Japan.

出版信息

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S314-8. doi: 10.1111/j.1440-1746.1997.tb00515.x.

DOI:10.1111/j.1440-1746.1997.tb00515.x
PMID:9407352
Abstract

The histopathology and clinical picture of hepatocellular carcinoma (HCC) varies between individual patients and regions. These variations are perhaps due to differences in the genetic alterations that precede hepatocarcinogenesis. In this study, the clinicopathological features of HCC were compared between southern African blacks and Japanese, indicating large differences in the frequency of underlying cirrhosis, grade of cancer cell differentiation and clinical course. Intra-abdominal bleeding and febrile, rapidly progressive HCC are more common among blacks. Such a difference is accounted for, in part, by frequent encapsulation of the tumour which is well differentiated, and grows slowly in an expanding fashion in Japan. Encapsulated HCC was not seen among the black patients studied. Other distinct clinicopathological types discussed in this paper include diffuse-type HCC which is usually caused by multiple portal spread occurring almost simultaneously; the clinical course is fulminant. Sclerosing carcinoma is frequently associated with hypercalcaemia in the United States, but not in Japan. Fibrolamellar carcinoma is nearly non-existent in Asia, whereas it is common among young adults in the West. Its prognosis is generally better than ordinary HCC. Hepatocellular carcinoma has a strong propensity to invade vessel and duct systems. Portal invasion does not produce distinct clinical signs although it may aggravate portal hypertension. Patients with tumour occlusion in the major portal vein may give rise to ischaemic hepatitis when blood pressure drops suddenly in the preterminal stage. Liver parenchyma develops submassive necrosis and clinically there is an acute rise in alanine aminotransferase (ALT). Invasion into a major hepatic vein and the inferior vena cava also occurs, but less frequently compared with portal invasion. The patient can live even with a tumour thrombus in the atrium crossing the tricuspid valves. Intraductal invasion causes acute jaundice as well as an occasional haemobilia with pain. We recently found that a distinct pathological type called 'extrahepatic growth' or 'pedunculated HCC' develops as a result of fusion of right-sided adrenal metastasis of HCC and the liver, perhaps through the 'adreno-hepatic fusion' which is rather common in cirrhotic livers.

摘要

肝细胞癌(HCC)的组织病理学和临床表现因个体患者及地区而异。这些差异可能归因于肝癌发生之前基因改变的不同。在本研究中,对南部非洲黑人和日本人的HCC临床病理特征进行了比较,结果表明在潜在肝硬化的发生率、癌细胞分化程度及临床病程方面存在很大差异。腹腔内出血以及发热、快速进展的HCC在黑人中更为常见。这种差异部分是由于在日本肿瘤常被包裹,分化良好,呈膨胀性缓慢生长。在所研究的黑人患者中未发现有包膜的HCC。本文讨论的其他独特临床病理类型包括弥漫型HCC,其通常由几乎同时发生的多灶门静脉播散引起;临床病程凶险。在美国,硬化性癌常伴有高钙血症,而在日本则不然。纤维板层癌在亚洲几乎不存在,而在西方的年轻人中较为常见。其预后通常优于普通HCC。肝细胞癌极易侵犯血管和胆管系统。门静脉侵犯虽可能加重门静脉高压,但不会产生明显的临床体征。在终末期前血压突然下降时,主要门静脉被肿瘤阻塞的患者可能会发生缺血性肝炎。肝实质出现亚大块坏死,临床上丙氨酸转氨酶(ALT)急剧升高。侵犯主要肝静脉和下腔静脉的情况也会发生,但与门静脉侵犯相比频率较低。即使肿瘤血栓穿过三尖瓣进入心房,患者仍可存活。胆管内侵犯会导致急性黄疸,偶尔还会引起伴有疼痛的胆道出血。我们最近发现,一种名为“肝外生长”或“带蒂HCC”的独特病理类型是由于HCC的右侧肾上腺转移与肝脏融合所致,可能是通过在肝硬化肝脏中相当常见的“肾上腺 - 肝融合”形成的。

相似文献

1
Hepatocellular carcinoma: clinicopathological aspects.肝细胞癌:临床病理学方面
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S314-8. doi: 10.1111/j.1440-1746.1997.tb00515.x.
2
Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants.肝细胞癌的自然史,包括纤维板层癌和肝内胆管癌变体。
J Gastroenterol Hepatol. 2002 Apr;17(4):401-5. doi: 10.1046/j.1440-1746.2002.02734.x.
3
Analysis of morphological factors of hepatocellular carcinoma in 98 autopsy cases with respect to pulmonary metastasis.98例尸检肝细胞癌肺转移的形态学因素分析
Acta Pathol Jpn. 1987 Sep;37(9):1389-404. doi: 10.1111/j.1440-1827.1987.tb02261.x.
4
A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?关于肝细胞癌矛盾性优势门静脉转移的假说。器官进化能否为人类病理学模式提供启示,反之亦然?
Med Hypotheses. 2019 May;126:109-128. doi: 10.1016/j.mehy.2019.03.019. Epub 2019 Mar 25.
5
Histological evaluation of intracapsular venous invasion for discrimination between portal and hepatic venous invasion in hepatocellular carcinoma.评估囊内静脉侵犯以鉴别肝细胞癌门静脉和肝静脉侵犯
J Gastroenterol Hepatol. 2010 Jan;25(1):143-9. doi: 10.1111/j.1440-1746.2009.06008.x. Epub 2009 Nov 24.
6
Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years.日本肝细胞癌的病理学。十年间连续尸检的232例病例。
Cancer. 1983 Mar 1;51(5):863-77. doi: 10.1002/1097-0142(19830301)51:5<863::aid-cncr2820510520>3.0.co;2-d.
7
Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel.肝细胞癌肝内转移:门静脉作为输出血管的作用。
Clin Exp Metastasis. 1996 Nov;14(6):520-9. doi: 10.1007/BF00115112.
8
Extended Right Hepatectomy and Inferior Vena Cava Graft Replacement for En Bloc Resection of Hepatocellular Carcinoma with Cavo-Hepatic Venous Confluence Invasion.整块切除侵犯肝静脉汇合部的肝细胞癌并进行右半肝切除和下腔静脉移植。
Ann Surg Oncol. 2018 Dec;25(13):3983. doi: 10.1245/s10434-018-6665-5. Epub 2018 Sep 11.
9
[The portal vein reconstruction during operations for hepatocellular carcinoma].[肝细胞癌手术中的门静脉重建]
Klin Khir. 2011 Sep(9):5-13.
10
Ex vivo hepatic venography for hepatocellular carcinoma in livers explanted for liver transplantation.离体肝静脉造影在肝移植中用于肝癌的诊断。
World J Surg Oncol. 2011 Sep 27;9:111. doi: 10.1186/1477-7819-9-111.

引用本文的文献

1
Radiotherapy with Targeted Therapy or Immune Checkpoint Inhibitors for Hepatocellular Carcinoma with Hepatic Vein and/or Inferior Vena Cava Tumor Thrombi.肝静脉和/或下腔静脉肿瘤血栓的肝细胞癌采用靶向治疗或免疫检查点抑制剂的放射治疗
J Hepatocell Carcinoma. 2024 Aug 5;11:1481-1493. doi: 10.2147/JHC.S464140. eCollection 2024.
2
[EHHADH is a key gene in fatty acid metabolism pathways in hepatocellular carcinoma: a transcriptomic analysis].[EHHADH是肝细胞癌脂肪酸代谢途径中的关键基因:一项转录组分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 May 20;43(5):680-693. doi: 10.12122/j.issn.1673-4254.2023.05.02.
3
Metastatic lung tumor from hepatocellular carcinoma with tumor thrombus invasion in the pulmonary vein: a case report.
转移性肺肿瘤源于肝细胞癌,伴肺静脉内肿瘤栓侵犯:病例报告。
J Cardiothorac Surg. 2023 Apr 28;18(1):167. doi: 10.1186/s13019-023-02230-4.
4
Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know.肝细胞-胆管细胞癌:多学科团队应了解的内容。
Diagnostics (Basel). 2022 Apr 2;12(4):890. doi: 10.3390/diagnostics12040890.
5
Diagnosis, treatment and prognosis of hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus.伴有下腔静脉/右心房瘤栓的肝细胞癌的诊断、治疗及预后
Oncol Lett. 2020 Oct;20(4):101. doi: 10.3892/ol.2020.11962. Epub 2020 Aug 7.
6
Expression And Biological Interaction Network Of RHOC For Hepatic Carcinoma With Metastasis In PBMC Samples.PBMC样本中RHOC在伴有转移的肝癌中的表达及生物相互作用网络
Onco Targets Ther. 2019 Nov 5;12:9117-9128. doi: 10.2147/OTT.S222235. eCollection 2019.
7
Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multi-center analysis.大分割放疗作为下腔静脉/右心房肿瘤血栓复发性肝细胞癌的挽救性治疗:一项多中心分析。
BMC Cancer. 2019 Jul 5;19(1):668. doi: 10.1186/s12885-019-5870-3.
8
Intracardiac Thrombosis and Heart Failure in a Patient with Hepatocellular Carcinoma and Cardiac Amyloidosis and an Implanted Cardiac Resynchronization Therapy Device.一名患有肝细胞癌、心脏淀粉样变性且植入心脏再同步治疗装置的患者发生的心内血栓形成与心力衰竭
Am J Case Rep. 2019 Jun 30;20:933-936. doi: 10.12659/AJCR.916672.
9
Right Atrium Invasion of Tumor Thrombus from Hepatocellular Carcinoma Incidentally Found on Transthoracic Echocardiogram.经胸超声心动图偶然发现的肝细胞癌肿瘤血栓侵犯右心房。
Hawaii J Med Public Health. 2018 Jun;77(6):131-134.
10
Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.伴有下腔静脉或右心房癌栓的肝细胞癌手术治疗结果
Surg Today. 2018 Sep;48(9):819-824. doi: 10.1007/s00595-017-1619-2. Epub 2017 Dec 26.